ADENOSINE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP26F9060 is a delivery order issued on August 19, 2026, under the base administrative contract SPE2DX25D9900. The contract was awarded to DMS Pharmaceutical Group Inc for the procurement of Adenosine Injection, identified by NSN 6505015303307. This procurement falls under NAICS code 424210 and was managed by the DLA Troop Support Medical Supply Chain. The order specifies the purchase of 715 units at a unit price of 153.08, resulting in a total contract value of 1,538 dollars. The materials are scheduled for delivery to Fort Bragg, North Carolina, by September 3, 2026. The overarching base contract, established on April 2, 2025, incorporates standard commercial item clauses and serves as a replacement for previous administrative agreements.
General Info
Contract Value
$153.08Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
